Stocktoria
Apogee Therapeutics, Inc. APGE
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-07-14
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$10.0B
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Operating income | -$285.6M | -$216.9M | -$93.0M | -$30.7M |
| Net income | -$255.8M | -$182.1M | -$84.0M | -$39.8M |
| Operating cash flow | -$227.4M | -$171.2M | -$74.8M | -$16.4M |
| Free cash flow | -$232.6M | -$172.3M | -$74.9M | — |
| Total assets | $937.1M | $754.0M | $401.4M | $152.1M |
| Total liabilities | $33.3M | $37.2M | $21.5M | $10.0M |
| Ratios | ||||
| Return on assets | -27.3% | -24.2% | -20.9% | -26.2% |
| Current ratio | 26.57 | 18.55 | 19.38 | 15.24 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 13,800 | $1.2M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001974640 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.